Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Current Leases (2022 - 2025)

Historic Current Leases for Exagen (XGN) over the last 4 years, with Q3 2025 value amounting to $1.2 million.

  • Exagen's Current Leases rose 1192.49% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year increase of 1192.49%. This contributed to the annual value of $1.1 million for FY2024, which is 1229.51% up from last year.
  • As of Q3 2025, Exagen's Current Leases stood at $1.2 million, which was up 1192.49% from $1.2 million recorded in Q2 2025.
  • In the past 5 years, Exagen's Current Leases registered a high of $1.2 million during Q3 2025, and its lowest value of $949000.0 during Q1 2022.
  • Moreover, its 4-year median value for Current Leases was $1.1 million (2024), whereas its average is $1.1 million.
  • In the last 5 years, Exagen's Current Leases soared by 1296.1% in 2023 and then crashed by 641.48% in 2024.
  • Quarter analysis of 4 years shows Exagen's Current Leases stood at $1.0 million in 2022, then dropped by 6.15% to $976000.0 in 2023, then rose by 12.3% to $1.1 million in 2024, then increased by 8.76% to $1.2 million in 2025.
  • Its Current Leases stands at $1.2 million for Q3 2025, versus $1.2 million for Q2 2025 and $1.1 million for Q1 2025.